title: Preparation and Characterization of SN-38-Encapsulated Phytantriol Cubosomes Containing α-Monoglyceride Additives.
abstract: SN-38 is a potent active metabolite of irinotecan that has been considered as an anticancer candidate. However, the clinical development of this compound has been hampered by its poor aqueous solubility and chemical instability. In this study, we developed SN-38-encapsulated cubosomes to resolve these problems. Six α-monoglyceride additives, comprising monocaprylin, monocaprin, monolaurin, monomyristin, monopalmitin, and monostearin, were used to prepare phytantriol (PHYT) cubosomes by probe sonication. The mean particle size, polydispersity index, and zeta potential values of these systems were around 190-230 nm, 0.19-0.25 and -17 to -22 mV, respectively. Small-angle X-ray scattering analyses confirmed that the SN-38-encapsulated cubosomes existed in the Pn̄3m space group both with and without the additives. The monoglyceride additives led to around a two-fold increase in the solubility of SN-38 compared with the PHYT cubosome. The drug entrapment efficiency of PHYT cubosomes with additives was greater than 97%. The results of a stability study at 25°C showed no dramatic changes in the particle size or polydispersity index characteristics, with at least 85% of the SN-38 existing in its active lactone form after 10 d, demonstrating the high stability of the cubosome nanoparticles. Furthermore, approximately 55% of SN-38 was slowly released from the cubosomes with additives over 96 h in vitro under physiological conditions. Taken together, these results show that the SN-38-encapsulated PHYT cubosome particles are promising drug carriers that should be considered for further in vivo experiments, including drug delivery to tumor cells using the enhanced permeability and retention effect.
authors.affiliation: Laboratory of Pharmaceutical Engineering & Drug Delivery Science, Graduate School of Integrated Pharmaceutical & Nutritional Sciences, University of Shizuoka.
authors.forename: Md Ashraf
authors.initials: MA
authors.lastname: Ali
authors.forename: Shuji
authors.initials: S
authors.lastname: Noguchi
authors.forename: Yasunori
authors.initials: Y
authors.lastname: Iwao
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Oka
authors.forename: Shigeru
authors.initials: S
authors.lastname: Itai
mesh_terms: D002166:Camptothecin / Q000031:analogs & derivatives* / Q000737:chemistry; D005233:Fatty Alcohols / Q000138:chemical synthesis / Q000737:chemistry*; D000077146:Irinotecan; D008968:Molecular Conformation; D050178:Monoglycerides / Q000737:chemistry*; D053758:Nanoparticles / Q000737:chemistry; D010316:Particle Size; D013499:Surface Properties
chemical_list: D005233:Fatty Alcohols; D050178:Monoglycerides; D000077146:Irinotecan; C508873:3,7,11,15-tetramethyl-1,2,3-hexadecanetriol; D002166:Camptothecin